+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
CAR-T Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

CAR-T Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • January 2024
  • 174 Pages
  • Global
From
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1699 Pages
  • Global
From
HPV Associated Disorders Market Report 2025 - Product Thumbnail Image

HPV Associated Disorders Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells), End User, Application, Therapeutic Areas - Global Forecast 2025-2030 - Product Thumbnail Image

Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells), End User, Application, Therapeutic Areas - Global Forecast 2025-2030

  • Report
  • March 2025
  • 194 Pages
  • Global
From
Generic Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Generic Pharmaceuticals Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis (PPV-MF) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 161 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 1369 Pages
  • Global
From
Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • June 2022
  • 111 Pages
  • Global
From
Red Biotechnology Market Report and Forecast 2024-2032 - Product Thumbnail Image

Red Biotechnology Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 172 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
Metastatic Breast Cancer Treatment Market by Treatment Type, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market by Treatment Type, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 190 Pages
  • Global
From
LAMEA T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 125 Pages
  • Africa, Middle East
From
North America T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 111 Pages
  • North America
From
Asia Pacific T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 125 Pages
  • Asia Pacific
From
Europe T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 124 Pages
  • Europe
From
Loading Indicator